Guna Liver Plus Pellet
NDC Package 17089-478-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Guna Liver Plus (sodium pyruvate - silybum marianum seed - chelidonium majus - fumaric acid - pork liver - taraxacum officinale - lycopodium clavatum spore - sodium sulfate - phosphorus - berberis vulgaris root bark) pellets is turn tube upside down and rotate cap to release pellets into cap. This formulation utilizes a pellet delivery system. Marketed by Guna Spa, this product is identified by NDC 17089-478.

Identification & Billing

NDC Package Code
17089-478-20
Package Description
2 TUBE in 1 BOX / 4 g in 1 TUBE
Product Code
11-Digit Billing Format
17089047820

Clinical Specifications

Proprietary Name
Guna Liver Plus
Non-Proprietary Name
Sodium Pyruvate - Silybum Marianum Seed - Chelidonium Majus - Fumaric Acid - Pork Liver - Taraxacum Officinale - Lycopodium Clavatum Spore - Sodium Sulfate - Phosphorus - Berberis Vulgaris Root Bark
Substance Name
Berberis Vulgaris Root Bark; Chelidonium Majus; Fumaric Acid; Lycopodium Clavatum Spore; Phosphorus; Pork Liver; Silybum Marianum Seed; Sodium Pyruvate; Sodium Sulfate; Taraxacum Officinale
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Turn tube upside down and rotate cap to release pellets into cap. Unscrew cap and without touching pellets tip them into the mouth under the tongue. Allow to dissolve Take 15 minutes before meals.

Regulatory & Marketing

Labeler Name
Guna Spa
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
02-17-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (17089-478). Click a package code to view its specific billing and regulatory data.

1 TUBE in 1 BOX / 4 g in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17089-478-20 identifies a specific commercial package of 2 tube in 1 box / 4 g in 1 tube of Guna Liver Plus, a human over the counter drug labeled by Guna Spa. This pellet is formulated for oral use and contains berberis vulgaris root bark; chelidonium majus; fumaric acid; lycopodium clavatum spore; phosphorus; pork liver; silybum marianum seed; sodium pyruvate; sodium sulfate; taraxacum officinale as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guna Spa on February 17, 2021. The current certification is valid through December 31, 2026.

How is this Guna Spa product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17089047820. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
17089-478-20
11-Digit CMS (5-4-2)
17089-0478-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.